Depression in Rheumatoid Arthritis: A Systematic Review of the Literature With Meta-Analysis

By C. Dickens, L. McGowan, D. Clark-Carter, F. Creed. Psychosomatic Medicine, 2002

652 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/dec5983bb0070c682041267c691c18d141fe9342

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. K. Smarr
2. Autumn L. Keefer

In Rheumatology

1. K. Smarr
2. Autumn L. Keefer

Citations in the corpus

• Economic impact of musculoskeletal disorders (MSDs) on work in Europe. (2015, background): “Individuals with MSDs are also likely to have depression or anxiety problems related to their conditions [16,17].”
• The multimorbidity interaction severity index (MISI) (2017, background): “Diseases such as rheumatoid arthritis can cooccur with the other conditions, though not necessarily in relation to the typical cluster.([47]) In the low conflict case, these prevalent diseases (iron deficiency anemia, diabetes mellitus type II, panic disorder, arterial hypertension, gastritis type C”
• Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels (2019, background): “, 2013); people with chronic immune-mediated inflammatory diseases such as rheumatoid arthritis exhibit a higher prevalence of depression (Dickens et al., 2002).”
• Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta‐Analytic Review (2003, background): “rheumatoid arthritis, another meta-analysis has recently confirmed this finding (22)).”
• The Bidirectional Relationship of Depression and Inflammation: Double Trouble (2020, background): “Thus, there is an increased risk of developing subsequent autoimmune diseases (rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus) in depressed patients (Andersson et al., 2015; Dickens et al., 2002; Euesden et al., 2017; Kurina et al., 2001; Patten et”
• Measures of depression and depressive symptoms: Beck Depression Inventory‐II (BDI‐II), Center for Epidemiologic Studies Depression Scale (CES‐D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire‐9 (PHQ‐9) (2011, methodology): “A recent review of use in rheumatoid arthritis patients found much larger effect sizes when the HADS was used compared to other measures of depression (50).”